CCEP Q4 2018 Earnings Small EPS Miss amid Operational Challenges SARO Q1 2026 Earnings EPS Misses Estimates Stock Advances on Operational Resilience GREE Q1 2025 Earnings NarrowerthanExpected Loss Amid Crypto Headwinds REPL Q1 2026 Earnings Narrower Than Expected Loss but Revenue Remains Elusive Lantern Pharma LTRN Q1 2026 Earnings EPS Beats Estimates by 183 Despite Absence of Revenue VLYPO Q1 2026 Earnings EPS Beats Estimates by 507 Amid Steady Performance